While many of these patients eventually will need treatment with insulin, little is known about the effects of insulin treatment on histopathological parameters and hepatic gene expression in diabetic patients with co-existing NAFLD and NASH. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.